MJNA Up 6% on Strong Volume
Medical Marijuana Inc.
2665 Ariane Drive Suite 207
San Diego, CA 92117
Toll Free: 888-OTC-MJNA (888-682-6562)
Fax: 888-651-0349
medicalmarijuanainc.com
PROFILE:
Medical Marijuana Inc. (MJNA) is the first publicly held company vested in the medical marijuana and industrial hemp markets. The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. Medical Marijuana Inc. does not grow, sell, manufacture or distribute marijuana or any other substances that violate the United States Controlled Substance Act.
These products range from patented and proprietary based cannabinoid products, to whole plant or isolated high value extracts for the pharmaceutical, nutraceutical and cosmiceutical industries.
The company’s services range from medical clinic management to the capitalization and development of existing industry leaders. These services include development of cannabinoid based health and wellness products, licensing of its proprietary testing, labeling, packaging and standardization methods for the medicinal herb industry.
Medical Marijuana Inc.’s patented and proprietary technologies include the only pharmaceutical grade vertical Biotechnology Company specializing in the standardization, production and extraction of medicinal cannabinoids. Technologies also include pre and post production tracking, germplasm references, packaging and processing to ensure consistency and genetic purity.
Operational and Development Highlights:
Operating highlights for the second quarter 2013 are as follows:
HempMedsPX
- Launched HempMedsPX to serve as the master distributor and contracted marketing company for the Medical Marijuana, Inc. portfolio of products.
- HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies.
- Departments added include: marketing, sales, logistics, and customer service.
- As of June, 30 2013, ten (10) additional team members were hired, including a Director of Communications, a Director of Sales and Marketing, additional marketing officers, a sales team, logistics personnel, and customer service.
- In addition to working with MJNA and CannaVest, HempMedsPX anticipates offering mainstream marketing, sales, customer service, and logistics for the cannabis industry in the future.
- Launched the Marketing and Sales for CBD-Rich Hemp Oil (Hemp based Cannabidiol) Real Scientific Hemp Oil (RSHO)
CanChew Biotechnologies
- Annual board meeting was held in San Diego from July 20-24, 2013.
- The CanChew Biotechnologies Board of Directors unanimously elected three new officers for the company: Dr. George E. Anastassov, MD, DDS, Exec. MBA as Chief Executive Officer (CEO);Dr. Philip. A. Van Damme, DMD, MD, PhD as Chief Medical Officer (CMO); and Lekhram Changoer, MSc, BSc as Chief Technology Officer (CTO).
- MedChewRX, a cannabis-based THC/CBD pharmaceutical drug, will continue with its clinical development this year and into 2014.
- HempMedsPX has begun marketing and sales of the CanChew gum for Cannagum Marketing Group, a wholly-owned subsidiary of CanChew Biotechnologies.
Canipa Holdings
- Closed exclusive worldwide sales, distribution and marketing agreement with Europe-based pharmaceutical/nutraceutical/cosmetics company.
- Due to the fact that the company's products are currently marketed for medical claims in Europe, Canipa must re-brand the products without their medical claims per FDA regulations before the products go to market in the United States.
PhytoSPHERE Systems
- PhytoSPHERE received its 8 million dollar quarterly payment from CannaVest. 750,000 dollars of which was paid in cash, and the balance (7,500,000 dollars) was paid in stock as per its contracted obligations.
Red Dice Holdings
The company continued to expand its portfolio of innovative products.
Wellness Managed Services
The company hired a Sales and Marketing Director for the purpose of expanding and further developing WMS' service offerings, and to assist with the integration of WMS' products and services into the MJNA portfolio.
Update on DTC
The company had previously submitted all requested documentation from the Depository Trust Corporation (DTC) for the requested "chill" removal, since then the DTC has requested some additional documentation which will be submitted to them in April. Our corporate counsel has addressed in writing and written a legal opinion letter for the DTC to address their questions.
Update on up listing and fully reporting status with SEC:
The company has positioned itself to become fully reporting with the Securities and Exchange Commission (SEC) once the twenty four month audit history is completed by the PCAOB auditing firm. The company has hired a Public Accounting and Auditing firm to complete all of the necessary paperwork, once completed it will be submitted to our PCAOB auditing firm for final approval and completion. Then the company's counsel will prepare the corporate registration statement for review and approval from the Securities and Exchange Commission.
Forward Looking Disclaimer
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc to be materially different from the statements made herein.
Food and Drug Administration (FDA) Disclosure
Information found on this site is not intended to diagnose, cure, treat, or prevent any disease. These statements and subsequent links found within this site have not been evaluated by the Food and Drug Administration (FDA).
Medical Disclaimer
Please read this agreement entirely and carefully before using this area of the Medical Marijuana Inc website (medicalmarijuanainc.com). By using the medicalmarijuanainc.com site, you agree to be bound by the terms and conditions below and in the medicalmarijuanainc.com Privacy Policy.
Disclaimer About Medical Information:
The information and reference materials contained here are intended solely for the general information of the reader. It is not to be used for treatment purposes, but rather for discussion with the patient's own physician. The information presented here is not intended to diagnose health problems or to take the place of professional medical care. The information contained herein is neither intended to dictate what constitutes reasonable, appropriate or best care for any given health issue, nor is it intended to be used as a substitute for the independent judgment of a physician for any given health issue. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. The major limitation of informational resources like medicalmarijuanainc.com is the inability to take into account the unique circumstances that define the health issues of the patient. If you have persistent health problems or if you have further questions, please consult your health care provider. All visitors to this and other medicalmarijuanainc.com associated web sites agree to read and abide by the complete terms of this agreement. |
|
Pink Sheets: MJNA
Market Value:
145,772,676 dollars a/o Sep 06, 2013
Shares Outstanding:
946,575,818 a/o Jun 30, 2013
Float:
411,045,323 a/o Mar 31, 2013
Authorized Shares:
950,000,000 a/o Jun 30, 2013
Shareholders of Record:
585 a/o Mar 31, 2013
Transfer Agent:
First American Stock Transfer, Inc.
RECENT NEWS:
HempMedsPX to Showcase Hemp Cannabidiol Products From Medical Marijuana Inc. at Natural Products Expo East
Medical Marijuana Inc.'s HempMedsPX to Exhibit at New York Wholesale Expo
KEY EXECUTIVES:
Michelle Sides
COO
Michael Llamas
President
Robert Plomgren
CFO
Secretary
Treasurer
|
